Looks like you’re on the UK site. Choose another location to see content specific to your location
GE Healthcare’s FlexFactory platform to be used by Arven Pharmaceuticals
GE Healthcare has announced that Arven Pharmaceuticals has selected its FlexFactory manufacturing platform to facilitate plans to expand its Turkish production capabilities.
The company is planning to broaden the scope of its facility in Kirklareli to better support healthcare needs by bringing biopharmaceuticals to local markets faster, whilst also allowing better access to the wider European region.
With the FlexFactory platform, which is based on integrated single-use technologies, the firm will be able to establish flexible and efficient biomanufacturing operations, with the resulting productivity improvements supporting Arven's biosimilars pipeline.
Sven Henrichwark, general manager for GE Healthcare's global commercial bioprocess business, said: "We are excited to contribute to Arven's development by delivering a robust and flexible biomanufacturing solution that also includes final qualification and training."
Turkey is currently Europe's seventh largest pharmaceutical market and is in the midst of active efforts to grow and transform its healthcare sector, with the aim of reaching a 60 percent local production goal for its pharmaceutical medicines by 2023.
With over 20 years of experience within the medical devices market, we at Zenopa have the knowledge, skills and expertise to help find the right job for you. To find out more about the current medical device roles we have available, you can search for the latest job roles, register your details, or contact the team today.
We have hundreds of jobs available across the Healthcare industry, find your perfect one now.
Stay informed
Receive the latest industry news, Tips
and straight to your inbox.
- Share Article
- Share on Twitter
- Share on Facebook
- Share on LinkedIn
- Copy link Copied to clipboard